Karlin Daniel
SEC CIK 1897618 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DFTX | Definium Therapeutics, Inc. | Chief Medical Off | 803.7K | — | $1.21M | 32 | 2022-02-26 | 2026-09-14 |
Most active insiders at DFTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barrow Robert | CEO, Dir | — | $3.08M |
| 2 | Sullivan Mark | CLO | — | $1.04M |
| 3 | Karlin Daniel | Chief Medical Off | — | $748.9K |
| 4 | Roberts Brandi | CFO | — | $135.7K |
| 5 | Wiley Matthew T. | Chief Commercial Off | — | $129.1K |
| 6 | Adsett Roger | Dir | — | — |
| 7 | CRYSTAL ROGER | Dir | — | — |
| 8 | Bruhn Suzanne Louise | Dir | — | — |
| 9 | Krebs Andreas | Dir | — | — |
| 10 | Vallone Carol A | Dir | — | — |
Transactions 32
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 08:30 | 2026-09-14 | DFTX | Definium Therapeutics, Inc. | Karlin Daniel | Chief Medical Off | A - Grant | $0.00 | +200.0K | 803.7K | +33% | $0 | |
| 2026-08-12 08:30 | 2026-08-12 | DFTX | Definium Therapeutics, Inc. | Karlin Daniel | Chief Medical Off | A - Grant | $0.00 | +100.0K | 603.3K | +20% | $0 | |
| T | 2026-06-26 16:30 | 2026-06-25 | DFTX | Definium Therapeutics, Inc. | Karlin Daniel | Chief Medical Off | S - Sale | $45.03 | -10.0K | 503.3K | -2% | -$451.9K |
| 2026-06-22 09:45 | 2026-06-22 | DFTX | Definium Therapeutics, Inc. | Karlin Daniel | Chief Medical Off | A - Grant | $0.00 | +100.0K | 513.3K | +24% | $0 | |
| T | 2026-03-26 | 2026-03-25 | DFTX | Definium Therapeutics, Inc. | Karlin Daniel | Chief Medical Off | S - Sale | $18.47 | -8,018 | 413.3K | -2% | -$148.1K |
| 2026-02-05 | 2026-02-03 | DFTX | Definium Therapeutics, Inc. | Karlin Daniel | Chief Medical Off | A - Grant | $0.00 | +150.0K | 575.0K | +35% | $0 | |
| T | 2025-12-29 | 2025-12-26 | DFTX | Definium Therapeutics, Inc. | Karlin Daniel | Chief Medical Off | S - Sale | $13.15 | -5,600 | 425.0K | -1% | -$73.6K |
| T | 2025-09-26 | 2025-09-25 | DFTX | Definium Therapeutics, Inc. | Karlin Daniel | Chief Medical Off | S - Sale | $9.77 | -7,704 | 430.6K | -2% | -$75.3K |
| T | 2025-06-26 | 2025-06-25 | DFTX | Definium Therapeutics, Inc. | Karlin Daniel | Chief Medical Off | S - Sale | $6.80 | -7,848 | 438.3K | -2% | -$53.4K |
| T | 2025-03-26 | 2025-03-25 | DFTX | Definium Therapeutics, Inc. | Karlin Daniel | Chief Medical Off | S - Sale | $6.74 | -6,836 | 446.2K | -2% | -$46.1K |
| 2025-03-13 | 2025-03-12 | DFTX | Definium Therapeutics, Inc. | Karlin Daniel | Chief Medical Off | A - Grant | $0.00 | +115.0K | 453.0K | +34% | $0 | |
| 2024-12-27 | 2024-12-26 | DFTX | Definium Therapeutics, Inc. | Karlin Dan | Chief Medical Off | S - Sale | $7.43 | -6,643 | 338.0K | -2% | -$49.4K | |
| T | 2024-09-25 | 2024-09-25 | DFTX | Definium Therapeutics, Inc. | Karlin Dan | Chief Medical Off | S - Sale | $5.98 | -6,871 | 344.7K | -2% | -$41.1K |
| T | 2024-06-25 | 2024-06-25 | DFTX | Definium Therapeutics, Inc. | Karlin Dan | Chief Medical Off | S - Sale | $7.22 | -6,925 | 351.5K | -2% | -$50.0K |
| T | 2024-03-26 | 2024-03-25 | DFTX | Definium Therapeutics, Inc. | Karlin Dan | Chief Medical Off | S - Sale | $9.50 | -6,578 | 358.5K | -2% | -$62.5K |
| 2023-12-26 | 2023-12-26 | DFTX | Definium Therapeutics, Inc. | Karlin Dan | Chief Medical Off | S - Sale | $3.63 | -6,774 | 365.0K | -2% | -$24.6K | |
| M | 2023-09-25 | 2023-09-25 | DFTX | Definium Therapeutics, Inc. | Karlin Dan | Chief Medical Off | S - Sale | $3.57 | -6,918 | 371.8K | -2% | -$24.7K |
| M | 2023-06-27 | 2023-06-27 | DFTX | Definium Therapeutics, Inc. | Karlin Dan | Chief Medical Off | S - Sale | $3.20 | -6,783 | 378.7K | -2% | -$21.7K |
| 2023-03-17 | 2023-03-14 | DFTX | Definium Therapeutics, Inc. | Karlin Dan | Chief Medical Off | A - Grant | $0.00 | +125.0K | 385.5K | +48% | $0 | |
| 2023-03-02 | 2023-03-01 | DFTX | Definium Therapeutics, Inc. | Karlin Dan | Chief Medical Off | S - Sale | $3.51 | -3,577 | 260.5K | -1% | -$12.6K | |
| 2022-12-22 | 2022-12-21 | DFTX | Definium Therapeutics, Inc. | Karlin Dan | Chief Medical Off | S - Sale | $2.69 | -1,211 | 264.1K | -0.5% | -$3,258 | |
| M | 2022-10-27 | 2022-10-25+ | DFTX | Definium Therapeutics, Inc. | Karlin Dan | Chief Medical Off | S - Sale | $2.91 | -1,185 | 265.3K | -0.4% | -$3,452 |
| M | 2022-09-27 | 2022-09-26+ | DFTX | Definium Therapeutics, Inc. | Karlin Dan | Chief Medical Off | S - Sale | $5.70 | -1,205 | 267.1K | -0.4% | -$6,870 |
| 2022-09-01 | 2022-08-31 | DFTX | Definium Therapeutics, Inc. | Karlin Dan | Chief Medical Off | S - Sale | $11.67 | -1,204 | 267.7K | -0.4% | -$14.1K | |
| M | 2022-07-27 | 2022-07-25+ | DFTX | Definium Therapeutics, Inc. | Karlin Dan | Chief Medical Off | S - Sale | $0.69 | -18.2K | 4.03M | -0.4% | -$12.6K |
| 2022-06-28 | 2022-06-27 | DFTX | Definium Therapeutics, Inc. | Karlin Dan | Chief Medical Off | S - Sale | $0.7 | -26.2K | 4.05M | -0.6% | -$18.4K | |
| 2022-05-31 | 2022-05-27 | DFTX | Definium Therapeutics, Inc. | Karlin Dan | Chief Medical Off | S - Sale | $0.82 | -9,555 | 4.08M | -0.2% | -$7,835 | |
| 2022-05-26 | 2022-05-25 | DFTX | Definium Therapeutics, Inc. | Karlin Dan | Chief Medical Off | S - Sale | $0.77 | -8,242 | 4.09M | -0.2% | -$6,346 | |
| 2022-04-27 | 2022-04-26 | DFTX | Definium Therapeutics, Inc. | Karlin Dan | Chief Medical Off | F - Tax | $0.81 | -13.0K | 4.10M | -0.3% | -$10.6K | |
| 2022-03-29 | 2022-03-28 | DFTX | Definium Therapeutics, Inc. | Karlin Dan | Chief Medical Off | F - Tax | $1.17 | -10.2K | 4.11M | -0.2% | -$11.9K | |
| D | 2022-03-28 | 2022-03-24 | DFTX | Definium Therapeutics, Inc. | Karlin Dan | Chief Medical Off | A - Grant | $0.00 | +950.0K | 4.12M | +30% | $0 |
| 2022-03-01 | 2022-02-26 | DFTX | Definium Therapeutics, Inc. | Karlin Dan | Chief Medical Off | F - Tax | $1.21 | -118.1K | 3.17M | -4% | -$143.0K |
Purchase Sale Sale after option exercise All abbreviations